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Depression is a mental illness that is increasingly rampant in our society. With its 
prevalence, various drugs have become commonplace for treatment. Many of these drugs are 
serotonin reuptake inhibitors, or SSRIs. These drugs are able to mitigate symptoms of depression 
such as rumination and anxiety. However, they are not very successful in treating the 
amotivation and anergia that are seen in these patients. In order to investigate which drugs will 
be the most successful in treating the symptoms of depression, it is important to develop an 
animal model that can accurately represent the motivational symptoms of depression in humans. 
The goal of the present study was to use female and male rats to develop electroencephalography 
(EEG) markers that can be readily translatable to the pathophysiology of female and male 
patients with depression. In this study, tetrabenazine (TBZ), a vesicular monoamine transporter-2 
(VMAT-2) inhibitor, or a vehicle (VEH) control, was administered to a group of 8 female rats 
and 7 male rats prior to measuring EEG in the home cage. Recordings were taken from each 
treatment condition in the medial prefrontal cortex (mPFC), motor (M1/M2), and medial parietal 
(mParietal) cortices to investigate the effect of TBZ on these cortices and to determine whether 
they are comparable to the neurological markers associated with depression in humans. It was 
found that male rats demonstrated a predominant peak frequency at baseline in EEG activity 
across all three regions in the alpha/theta frequency range (4-12 Hz, with a sharp peak at 6-8.5 
Hz frequency range). The sharp 6-8.5 Hz peak was suppressed when TBZ was administered in a 
1.0 mg/kg dose. The EEG recordings of the female rats were not significantly affected. These 
findings can be used as a foundation to develop further EEG studies in behaving rats that can be 





Major depressive disorder affects a large portion of the population, with over 264 million 
people being diagnosed with this across the globe (WHO, 2020). As stated by the National 
Institutes of Health, depression is “a common but serious mood disorder. It causes severe 
symptoms that affect how you feel, think, and handle daily activities” (Depression 2018). As the 
number of individuals affected by depression has increased over the years, more people have had 
to grapple with the cognitive, emotional, and physical symptoms that come with this 
psychopathology (Stahl, 2006; Treadway and Zald, 2011; Fava et al. 2014; Salamone et al. 
2016a).  
 One major cognitive impairment of depression is amotivation. Specifically, when given 
assessments for effort-related decision making, humans with depression are less likely to choose 
the option that requires more effort (Treadway et al. 2012a; Yang et al. 2014). In humans, this 
lack of motivation can severely reduce the quality of one’s life, affecting one’s ability to work, 
attend school, and maintain relationships (WHO 2020). To combat these symptoms and improve 
quality of life, it is important to develop an understanding of how depression works and 
determine which drug treatments are the most effective. This necessitates animal models for 
research, which allow for the use of controlled settings as well as tools and methods that could 
not be ethically used in humans (Hitzemann 2000). Through the use of animal models, 
neurochemical changes that lead to effort-related motivation dysfunctions have been well-
established. For example, interference in the dopamine transmission of the ventral striatum 
lowers participation in high-effort instrumental activities elicited by conditioned stimuli, whereas 
low-effort instrumental activities are unaffected (Aberman and Salamone 1999; Salamone and 
Correa 2012). Within our laboratory, we have used the effort-based choice model on rats to study 
 
 
these motivational dysfunctions in psychopathology. We have conducted investigations in which 
tetrabenazine (TBZ) was administered to rats. TBZ works by inhibiting the vesicular monoamine 
transporter 2 (VMAT-2) to deplete dopamine, altering effort-based choice behavior in rats. In 
comparison with administration of a vehicle control, TBZ reduced the number of lever presses, 
while the consumption of concurrently available laboratory chow increased (Randall et al. 2014;  
Yohn et al. 2016a). Thus, similarly to humans, rats demonstrate a low-effort bias when subjected 
to the pharmacological conditions that have also shown to produce a low-effort bias in humans 
(Salamone et al. 2016a,b,c; Yohn et al. 2016a,b,c). Moreover, administration of TBZ can induce 
depressive symptoms in people, including fatigue and amotivation (Salamone et al. 2016a). 
In terms of the neural basis of depression, there is evidence demonstrating that 
mesolimbic DA circuits in the forebrain in conjunction with the ventral striatum, prefrontal 
cortex, and ventral pallidum play a significant role in the selection of high-effort activities 
(Salamone et al. 1991, 1994; 2007, 2016a,b, 2018; Walton et al. 2003; Floresco and Ghods-
Sharifi 2007; Mingote et al. 2008; Farrar et al. 2008, 2010; Winstanley and Floresco 2016). Still, 
more research is needed to properly identify and describe the psychopathology of neural circuits 
in effort-related dysfunctions.  
Recent studies have suggested that cortical electroencephalographic markers may differ 
between  healthy and depressed individuals. There has been particular emphasis on the frontal 
cortex, which is primarily responsible for cognitive effort tasks, or CET performance 
(Winstanley and Floresco 2016). In a study of 37 depressed and 35 nondepressed individuals, the 
frontal alpha EEG asymmetry of the depressed individuals at rest was significantly increased 
(Gollan et al. 2014). Further, evidence also shows that depressed people have a reduction of EEG 
markers in this cortex that are present during the performance of motivated behaviors and in the 
 
 
anticipation of reinforcement (Nelson et al. 2018; Gheza et al. 2019). Specifically, it has been 
determined that bilateral asymmetry of EEGs in the frontal cortex in humans is an important 
marker for effort-related motivation (Allen, Coan, & Nazarian, 2004; Coan and Allen 2004).  
 In addition to EEGs, imaging has also been utilized to investigate the neural basis of 
anergia, psychomotor retardation (Hickie et al. 1999; Capuron et al. 2007), and effort-related 
decision making (Wardle et al. 2011; Schouppe et al. 2014; Huang et al. 2016; Hogan et al. 
2018; Aridan et al. 2019). The results have been consistent with animal studies in that the 
striatum and frontal cortex are important for effort-based decision making as well as approach 
motivation, or motivation which is widely prompted by positive stimuli (Winstanley and 
Floresco 2016; Harmon-Jones et al. 2013).  
 The purpose of the present experiments was to further investigate these findings, 
comparing the characteristics of the mPFC, M1/M2, and mParietal EEG readings in the left and 
right hemispheres of awake male and female rats in baseline and TBZ-induced, DA-depleted 
conditions. The mPFC was the focus of this study due to the abundance of studies drawing 
connections between executive function, effort-based choice, decision making, and the prefrontal 
cortex. Additionally, the mPFC is thought to reflect the effects of TBZ on the ventral striatum 
and striatopallidal circuits that are important for effort-based decision making (Rotolo Ph.D. 
Dissertation, 2020). EEGs from the mParietal and M1/M2 cortices were recorded to serve as a 
point of reference for the mPFC while simultaneously ascertaining whether TBZ affected other 
cortical areas. In summation, this investigation was done to work towards creating physiological 
markers for altered DA transmission and effort-related dysfunction in preclinical animal models 




    
Materials and Methods 
 
Surgery 
Rats were anesthetized with 100 mg/kg of ketamine and 10 mg/kg of xylazine prior to being 
placed within the stereotaxic device for electrode implantation surgery. Surgical implantation of 
8 ¼” stainless-steel screw electrodes were performed on 8 untrained female rats and 7 untrained 
male rats (total n=15). The EEG electrodes were placed next to the mPFC, M1/M2, and 
mParietal in addition to two screws that served as ground and reference electrodes. Rats were 
monitored for pupil reflex, knee-jerk reflex, and breathing throughout the surgery. Recordings 
were carried out after a recovery period of 7 days.  
 
Electrophysiological Recording Experiment 
A Digital Lynx SX Electrophysiology System (Neuralynx) was used to record the EEG activity 
of female and male rats in the awake state. Wide-band activity (1-2000 Hz, 4006 samples/sec) 
was recorded using the Neuralynx system and was analyzed offline using MATLAB software 
(MathWorks Inc, Natick, MA). Approximately 1 minute of baseline EEG activity was recorded 
from each rat after a short period of reading stabilization following the connection of the rat to 
the Neuralynx system via cable. The rats were then injected intraperitoneally with either vehicle 
or TBZ (1.0 mg/kg). A lead time of 120 minutes elapsed before resuming recordings. The 







Signal processing and related procedures were carried out with the FieldTrip software package 
(Oostenveld et al. 2011; http://www.fieldtriptoolbox.org/) and custom scripts in MATLAB (The 
MathWorks, Natick, MA). The following steps were used to preprocess the EEG data: 1) data 
were mean subtracted; 2) data were divided into 1-s epochs for the purpose of removing the 
epochs that contained artifacts; 3) the first epoch and the last epoch were removed; 4) data was 
inspected to determine and remove the epochs that contained high-amplitude artifacts according 
to Z-score threshold criterion. 
  
Neurophysiological Analysis 
Power spectral analysis was carried out by first segmenting the preprocessed EEG data into 1-s 
epochs with 0.5-s overlap. We then used Welch’s overlapped averaged periodogram method 
(Welch, 1967) with a Hamming window on each epoch to estimate the power spectral density 













  EEG recordings were taken on 8 untrained female rats and 7 untrained male rats from 
their mPFC, M1/M2, and mParietal cortices via implanted EEG electrodes. A PSD was used to 
determine the effect of 1.0 mg/kg TBZ versus VEH treatment on EEG activity in awake female 
(n=8) (Figure 1) and male (n=7) rats (Figure 2). During baseline home cage EEG recording from 
the mPFC, M1/M2, and mParietal cortex of both freely moving male and female groups, the 
predominant peak in EEG activity in the lower frequency ranges in all three brain cortices is 
distinctly in the alpha/theta frequency range (4-12 Hz, with a sharp peak at 6-8.5 Hz frequency 
range). In order to correct for the baseline values, power of pre- and post-injection was 
subtracted from the baseline. In other words, the change from pre-injection to post-injection of 
TBZ or VEH was determined. The values were then analyzed by analysis of variance (ANOVA) 
mixed effects model. Across all three brain cortices, there was a significant sex x drug (vehicle 
versus TBZ) effect interaction (F(1,317) = 4.74, p < 0.05) (see Table 1). There was a sharp 6-8.5 
Hz peak that was not blunted in females (F(1,155) = 1.13, p = n.s.) (See Figure 1 and Table 2). 
However, the power of this peak was significantly affected by the drug in male rats (F(1,159) = 
5.01, p < 0.05) (see Figure 2 and Table 3). Thus, the effect of the drug was different in males 
versus females. Specifically, this peak was significantly blunted relative to vehicles by 









Table 1. ANOVA marginal test for fixed effects of sex (male versus female), drug (VEH versus 
TBZ), region (mPFC, M1/M2, mParietal), (left versus right) lr, and sex:drug (interaction of sex 
and drug). The effects of sex and drug approached significance (p = 0.08 < 0.5 ; p = 0.06 < 0.5). 
The interaction between sex and drug was significant, meaning the effect of the drug is different 


















Figure 1. The effects of the VMAT-2 inhibitor TBZ on bilateral EEG recordings in the mPFC, 
M1/M2, and mParietal cortices in female rats (mean +SEM; n=8). All rats were administered 
intraperitoneal injections of VEH or 1.0 mg/kg TBZ on one week and counterbalanced with 
either VEH or TBZ the following week. Females did not have a statistically significant 





Table 2. ANOVA marginal test for female rats. Parameters are fixed effects of drug (VEH 
versus TBZ), region (mPFC, M1/M2, mParietal), and lr. The effect of the drug was not 







Figure 2. The effects of the VMAT-2 inhibitor TBZ on bilateral EEG recordings in the mPFC, 
M1/M2, and mParietal cortices in male rats (mean +SEM; n=7). All rats were administered 
intraperitoneal injections of VEH or 1.0 mg/kg TBZ on one week and counterbalanced with 
either VEH or TBZ the following week. Males had a statistically significant suppression of the 6-




Table 3. ANOVA marginal test for male rats. Parameters are fixed effects of drug (VEH versus 










Our lab conducted these studies to determine the neurophysiological effects of TBZ on 
untrained, freely moving male and female rats. This involved using EEG recordings that focused 
on power spectral density analyses of signals from the bilateral mPFC, M1/M2, and mParietal 
cortices. The use of animal models to study effort and motivation is valid as the data collected 
from previous animal studies correlates to what is seen in patients with major depressive 
disorder. This investigation is one the first in a series that will lead to the studies of the 
electrophysiology of trained animals carrying out effort-related choice tasks. Performing 
investigations in trained animals is important to allow for the discovery of more sensitive 
electrophysiological biomarkers in males and females (Rotolo Ph.D. Dissertation, 2020). Thus, 
the present studies are necessary in order to develop the initial EEG markers that are readily 
translatable to humans. 
In this investigation, 8 female rats and 7 male rats were each surgically implanted with 
cortical EEG electrodes to record from the mPFC, M1/M2, and mParietal cortices. Based on 
recordings post-injection of TBZ compared to baseline along with a vehicle control, statistically 
significant results were found for male rats. The results demonstrated a predominant peak in 
EEG activity at baseline in all three brain cortices clearly in the alpha/theta frequency range (4-
12 Hz, with a sharp peak at 6-8.5 Hz frequency range). Using the ANOVA mixed effects model, 
the data shows that collapsed across all three brain regions, there was a significant sex x drug 
interaction (F(1,317) = 4.74, p < 0.05) (see Table 1). This peak remained unaffected in female 
rats (F(1,155) = 1.13, p = n.s.) (See Figure 1 and Table 2). In male rats, there was a significant 
suppression of the sharp 6-8.5 Hz peak (F(1,159) = 5.01, p < 0.05) (See Figure 2 and Table 3). In 
conclusion, the effect of the drug on the observed EEG power spectra was different in males 
 
 
versus females. Specifically, the peak frequency band was significantly blunted relative to 
vehicle by administration of 1.0 mg/kg TBZ in male rats, but not in females. This has potential 
implications that DA depletion seen in depressed individuals does not affect the male and female 
brain in the same manner. Additionally, a limitation of this investigation was that only one 
dosage amount (1.0 mg/kg TBZ) was used. For future studies, administering rats various dosages 
would allow for a deeper investigation of how the male and female brain are affected by different 
degrees of DA depletion.  
The findings of this investigation will also serve as a good foundation for future research 
on how frontal EEG recordings change during the performance of effort-related tasks. During the 
PROG lever pressing task, rats must press a lever a certain number of times to deliver favorable, 
carbohydrate-rich pellets that act as reinforcers for this behavior. As time goes on, the ratio of 
presses to released pellets progressively increases. During this task, it has been shown that with 
an increase in the lever pressing ratio, rats reach a break point during which they stop lever 
pressing and switch to consumption of the readily-accessible, but less preferable lab chow 
(Cordony 2019). According to Pizzagalli et al. (2005), Nelson et al. (2018), and Gheza et al. 
(2019), it is hypothesized that there will be alterations in frontal EEG activity when rats reach 
their break point. It has also been hypothesized that the administration of TBZ will result in a 
decrease in lever pressing and an increase in chow intake, which will also lead to changes in 
frontal EEG activity. More knowledge of EEG activity and electrophysiological biomarkers 
would allow for further investigation of neural circuitry via anterograde and retrograde tracing. 
Given the anatomical connections between the ventral striatum and ventral pallidum via the 
thalamus to the mPFC, and the role of this circuitry in effort-related decision making, it is 
important to investigate how different neural pathways are affected by TBZ (Fareri et al. 2017). 
 
 
Such findings would significantly deepen our understanding of the circuit mechanisms that are 
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